Corporate Governance
Overview
Our commitment to scientific excellence, operational efficiency, and customer focus positions us as a preferred partner in the industry. In this section, we highlight how Sai Life Sciences drives growth through strategic investments in infrastructure, technology and talent, all aimed at delivering value to our stakeholders.
Corporate Governance
Dr. K. Ranga Raju
Chairman
Krishna Kanumuri
Managing Director and CEO
Siva Chittor
Whole-Time Director & Chief Financial Officer
Ramesh G Iyer
Independent Director
Suchita Sharma
Independent Director
Dr. Dinesh V Patel
Independent Director
Siva Chittor
Whole-Time Director & Chief Financial Officer
Runa Karan
Company Secretary, Compliance Officer & Legal Head
Key items
Download
Committees of the board
Corporate Policies/Documents
Key items
Download
Familiarisation Programme for ID-FY26
Management ESOP Scheme 2018
ESOP Scheme 2008
Criteria for Making Payments to Non-Executive Directors
Anti-Sexual Harassment Policy
Archival Policy
Code of Conduct for BoD and SMPs
Code of conduct for NEDs
Corporate Social Responsibility Policy
Determining Material Subsidiaries
Disclosure of Contact details of KMP as per Reg 30(5)
Familiarisation Programme for Id
Nomination and Remuneration Policy
Policy for Evaluation of Performance of BoD
Policy for Familiarisation Programme for ID
Policy for Preservation of Documents
Policy for Determination of Materiality
Policy on Related Party Transactions
Policy to Promote Diversity of Board of Directors
Risk Management Policy
Code of Practices-Fair Disclosure of UPSI
Insider Trading Policy
Succession Policy
Terms and Conditions for appointment of Independent Director
UPSI Leak Inquiry Policy
Whistle Blower Policy
Material Contracts
Material Documents
Key items
Download
Certificate of Commencement for Business
Annual Reports of the Company for Fiscal year 2022
Annual Reports of the Company for Fiscal year 2023
Annual Reports of the Company for Fiscal year 2024
Agreement dated November 27, 2023 along-with amendment agreement dated July 10, 2024
BR taking on record the approval for OFS by each of selling shareholders
BR Approving RHP
Tripartite agreement between Company, NSDL and Registrar of the Offer
BR Approving the Offer and Related Matters
Tripartite agreement between Company, CDSL and Registrar of the Offer
Certificate of Incorporation
Vishvakarma Consultancy Services Consent Letter
Consent letters and authorisations from selling shareholders
Consents by Directors, Company Secretary, Compliance Officer and Legal Head, legal counsels to the Company, Bankers to the Company, Banker(s) to the Offer, the BRLMs, Syndicate Members, Registrar to the offer to act in respective capacities
Deloitte Consent Letter
Due diligence certificate dated July 24, 2024
BR Approving DRHP
Frost & Sullivan consent
Gift Deed along-with supplementary letter
In-principle listing approvals by NSE and BSE
Frost & Sullivan report
Loan utilization certificate
Certified Copies of MoA and AoA
BR and SR for approval of revised remuneration structure of Chairman and WTD
Certificate by Bashetty & Joshi certifying Basis for Offer price
Certificate by Bashetty & Joshi certifying details of Employee Stock options scheme
Certificate by Bashetty & Joshi certifying details of outstanding borrowings
Certificate by Bashetty & Joshi certifying KPIs
Certificate by Bashetty & Joshi certifying dues owed to material creditors, MSME enterprises and other creditors
Certificate by Bashetty & Joshi certifying weighted average cost of acquisition
Examination Report
Statement of Possible Special Tax Benefits certificate
Scheme of arrangement between Company, Sai Quest Syn and their respective shareholders and creditors along-with Valuation report
SEBI Final observation letter
Shareholders’ agreement dated March 27, 2019 along-with amendment agreement dated July 4, 2024
SR Approving Fresh Issue and Other Related Matters
IPO committee resolution taking on record consent to participate in OFS by each of selling shareholders
Audit committee resolution approving KPIs for disclosure
BR and SR for approval of revised remuneration structure of MD and CEO
Compliance
Key items
Download
EPFO Form 5A